We created a transgenic mouse on the FVB background in which the transgene is comprised of a strong constitutive promoter (CAG) driving expression of a dual reporter gene (luciferase and GFP). We called the original FVB mouse L2G85.
Stanford researchers in the Dai Lab have developed the first ultra-bright cubic-phase erbium-based rare-earth nanoparticles (α-ErNPs) with down-shifting luminescence at ~ 1600 nm for in vivo NIR-IIb (1500-1700 nm) imaging with deep penetration and high clarity.
Researchers at Stanford have developed a targeted delivery system using carbon nanotubes to specifically deliver cardiovascular drugs to treat atherosclerosis. A feature of atherosclerotic plaque is the accumulation of apoptotic cells.
Stanford researchers have invented a C-Aperture Nano-Tip which provides a new way to further enhance the optical resolution down to smaller than 15 nm.
Stanford researchers have developed a lanthanide-doped upconverting nanoparticle (UCNP) that emits very photostable and non-blinking light, and is bright enough to delineate tumor boundaries to the naked eye during surgery.
Stanford engineers have developed and tested a nanostructured thin film material that upconverts infrared to visible light and combines electrical and non-linear optical properties in the same layer.
Researchers in Prof. Hemamala Karunadasa's laboratory have developed inexpensive, robust, high capacity hybrid materials for reversible or irreversible capture of halogens (chlorine, bromine, and iodine gas).
Stanford researchers at the Airan Lab have developed a new method for robust and spatiotemporally precise non-invasive neuromodulation that could transform both basic and clinical neuroscience.
Stanford chemists have developed a scalable synthetic process to create a new class of viscous, stable phospholipid bilayer vesicles with tunable properties.
Researchers in Prof. Hongjie Dai's laboratory have combined graphene with metals and other inorganic elements to create a variety of hybrid materials that can be used for high performance electrocatalytic or electrochemical devices such as batteries and fuel cells.
Researchers in Prof. Hongjie Dai's laboratory have developed nanocarbon/inorganic nanoparticle hybrid materials for various electrocatalytic and electrochemical applications, such as batteries and fuel cells. Three types of hybrid materials have been created:
W.E. Moerner and Adam Cohen have patented the Anti-Brownian ELectrokinetic trap (ABEL trap) which can trap, measure, and manipulate sub-micron objects (e.g. single molecules) in solution at ambient temperature.
Researchers in Prof. James Swartz' laboratory have developed a rapid bioluminescence method for detecting and enumerating circulating tumor cells (CTCs) and other rare cells. This invention utilizes novel nanoparticle reagents which can specifically bind to cells of interest.
Researchers at Stanford and the University of Alberta have developed fluorinated amphiphilic nanoparticles that can be used to create low-cost, stable, bio-compatible droplets for microfluidics-based digital PCR or other high-throughput screening applications.